The first group contained largely clear cell variants, the second group was predominantly atypical WHO grade 2 meningiomas in which all samples had alterations on chromosome 22 and there was the highest frequency of patients diagnosed clinically with NF2. The gene discussed is NF2; the disease is meningioma.